glp 1 drugs and kidney function GLP-1 receptor agonists in patients with chronic disease either overweight or obesity Uncovering hidden opportunities in the

Although, at first glance, it is easy to overestimate the findings and assume they apply to everyone, this studys participants were a very specific group: older adults with type 2 diabetes

Diabetes 41 , 490501 (2023)

Wegovy is the same active ingredient, semaglutide, dosed higher and FDA-approved specifically for chronic weight management

What she's doing now Microdosing and strength training

Ozempic is not FDA-approved for the treatment of prediabetes (e.g., HbA1c or A1C of 5.76.4%)

Incorporating these foods not only supports your fluid intake but also offers important nutrients that help your body feel its best during GLP-1 therapy